Using pharmacogenomics to personalise drug therapy: which drugs, when and how [0.03%]
用药基因组学指导个体化药物治疗的策略：如何实施及应用案例分析
Sophie L Stocker,Thomas M Polasek
Sophie L Stocker
Pharmacogenomic testing provides information on whether a patient possesses gene variants that can influence drug exposure or response. It can be used as part of clinical decision-making to personalise drug therapy. Pharmacogenomic testing ...
Emma Mason,Kirsten Black
Emma Mason
Long-acting reversible contraceptive methods, including the contraceptive implant and intrauterine devices, are highly effective and cost-effective options for women who have no specific contraindications. Long-acting reversible contracepti...
Laxmi Iyengar,Jane Li
Laxmi Iyengar
Androgenetic alopecia, commonly referred to as male or female pattern hair loss, is a prevalent condition encountered in clinical practice. It is important to identify potential underlying causes and differentiate it from other forms of hai...
Jonathan J Chan
Jonathan J Chan
Psoriasis is an immune-mediated inflammatory disease with a genetic predisposition. Although manifesting predominantly as a hyperproliferative skin disorder, psoriasis is a systemic disease associated with a range of comorbidities including...
Alice Poulton,Lisa Hui
Alice Poulton
Australian health authorities recommend offering prenatal screening for fetal chromosome conditions, also known as aneuploidies (e.g. Down syndrome [trisomy 21]), to all pregnant individuals to support informed decision-making. Noninvasive ...
Amy Legg,Felicia Devchand,Amanda Gwee et al.
Amy Legg et al.
Vancomycin is an important antimicrobial for prophylactic, empirical and directed therapy of Gram-positive organisms. Therapeutic drug monitoring is recommended for all patients expected to receive vancomycin for more than 48 hours to optim...